Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy.

Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights. J Invest Dermatol (2014) 1.03

Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97

Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res (1996) 0.86

HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata. Arch Dermatol Res (1988) 0.80

Biologics in dermatology. Pharmaceuticals (Basel) (2013) 0.80

Survivin, p53, MAC, Complement/C3, fibrinogen and HLA-ABC within hair follicles in central and centrifugal cicatricial alopecia. N Am J Med Sci (2011) 0.75

Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions. Arch Dermatol Res (1991) 0.75

Alopecia areata. Nat Rev Dis Prim (2017) 0.75

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20

The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci (2000) 3.70

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56

Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol (1987) 3.40

Botulinum toxin for palmar hyperhidrosis. Lancet (1997) 3.17

Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02

Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93

What every dermatologist should know about homeopathy. Arch Dermatol (1996) 2.59

Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res (1998) 2.44

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28

The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol (2004) 2.27

D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci (2000) 2.13

Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol (1998) 2.09

The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet (1986) 1.98

Cell migration strategies in 3-D extracellular matrix: differences in morphology, cell matrix interactions, and integrin function. Microsc Res Tech (1998) 1.86

Lyonization and the lines of Blaschko. Hum Genet (1985) 1.86

T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest (2000) 1.85

Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol (1998) 1.83

Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol (2000) 1.82

Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80

Amoeboid leukocyte crawling through extracellular matrix: lessons from the Dictyostelium paradigm of cell movement. J Leukoc Biol (2001) 1.78

Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol (1994) 1.76

A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol (1985) 1.76

Hailey-Hailey disease. Eradication by dermabrasion. Arch Dermatol (1994) 1.73

Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73

Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67

Induction of hair growth in alopecia areata with D.N.C.B. Lancet (1977) 1.66

Type 2 segmental Cowden disease vs. Proteus syndrome. Br J Dermatol (2007) 1.63

Cutaneous manifestation of lethal genes. Hum Genet (1986) 1.59

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res (2001) 1.59

Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol (2001) 1.57

Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol (1991) 1.56

Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol (2003) 1.56

Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet (1996) 1.54

Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer (1994) 1.53

Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res (2000) 1.51

Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet (1992) 1.49

Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet (2000) 1.48

Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis? Eur Respir J (2003) 1.47

Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res (1999) 1.46

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46

Should elective lymph node dissection be used for treatment of primary melanoma? J Cancer Res Clin Oncol (1989) 1.44

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer (1987) 1.41

[What is a hamartoma?]. Ann Dermatol Venereol (1998) 1.39

Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma. J Cancer Res Clin Oncol (2004) 1.39

Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer (2003) 1.37

The CHILD syndrome. Congenital hemidysplasia with ichthyosiform erythroderma and limb defects. Eur J Pediatr (1980) 1.36

An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol (1995) 1.36

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol (1983) 1.35

Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices. Mol Biol Cell (1999) 1.33

Phacomatosis pigmentokeratotica: a melanocytic-epidermal twin nevus syndrome. Am J Med Genet (1996) 1.32

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity (2001) 1.26

Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood (2001) 1.25

Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol (1996) 1.24

Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol (1999) 1.24

Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res (1995) 1.24

Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (1983) 1.24

[Atrophodermia linearis Moulin. A new disease picture, following the Blaschko lines]. Hautarzt (1994) 1.22

Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J Pathol (2000) 1.20

Circadian rhythms of melatonin release from individual superfused chicken pineal glands in vitro. Proc Natl Acad Sci U S A (1980) 1.18

Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res (1997) 1.17

Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol (1993) 1.17

Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol (1999) 1.16

Dinitrochlorobenzene therapy for alopecia areata. Arch Dermatol (1978) 1.15

The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood (1999) 1.15

Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect Immun (2000) 1.14

Acrodermatitis acidemica secondary to malnutrition in glutaric aciduria type I. Eur J Dermatol (2001) 1.14

Phylogeny and dating of some pathogenic keratinophilic fungi using small subunit ribosomal RNA. J Med Vet Mycol (1996) 1.14

Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J Immunol (1995) 1.14

Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol (1984) 1.13

A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness. J Med Genet (2007) 1.13

Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol (2000) 1.13

The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol (1997) 1.13

Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer (1985) 1.12

Large aberrant Mongolian spots coexisting with cutis marmorata telangiectatica congenita (phacomatosis pigmentovascularis type V or phacomatosis cesiomarmorata). J Eur Acad Dermatol Venereol (2006) 1.12

Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of Gi-linked Ras/mitogen-activated protein kinase pathway. J Biol Chem (1999) 1.12

IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol (2000) 1.11

Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation. Immunology (1997) 1.11

Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci (1996) 1.11

X-linked dominant chondrodysplasia punctata. Review of literature and report of a case. Hum Genet (1979) 1.10

Manifestation of the lines of Blaschko in women heterozygous for X-linked hypohidrotic ectodermal dysplasia. Clin Genet (1985) 1.09

Cholesterol in pleural effusions. A diagnostic aid. Chest (1987) 1.09

Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines. J Leukoc Biol (2000) 1.08

Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis (1991) 1.07

[How are the Blaschko lines arranged on the scalp?]. Hautarzt (1984) 1.07

Immunohistochemistry in the evaluation of melanocytic tumors. Semin Diagn Pathol (1993) 1.07

Linear verrucous hemangioma. J Am Acad Dermatol (2000) 1.06

Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res (2007) 1.06

Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. J Invest Dermatol (1996) 1.05

Migration of dendritic cells in 3D-collagen lattices. Visualisation of dynamic interactions with the substratum and the distribution of surface structures via a novel confocal reflection imaging technique. Adv Exp Med Biol (1997) 1.05

Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol (2007) 1.04

Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol (2000) 1.04

Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology (1994) 1.04

Congenital brachydactyly and nail hypoplasia: clue to bone-dependent nail formation. Br J Dermatol (2005) 1.03

Localisation of gene for the naevoid basal-cell carcinoma syndrome. Lancet (1992) 1.03

Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer (1993) 1.03